These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17980561)

  • 21. Synthesis and in vitro evaluation of a novel thiolated chitosan.
    Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
    Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate.
    Kafedjiiski K; Föger F; Werle M; Bernkop-Schnürch A
    Pharm Res; 2005 Sep; 22(9):1480-8. PubMed ID: 16132360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and in vivo bioavailability study of an oral fondaparinux delivery system.
    Vetter A; Perera G; Leithner K; Klima G; Bernkop-Schnürch A
    Eur J Pharm Sci; 2010 Nov; 41(3-4):489-97. PubMed ID: 20705133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
    Millotti G; Samberger C; Fröhlich E; Bernkop-Schnürch A
    Biomacromolecules; 2009 Nov; 10(11):3023-7. PubMed ID: 19821557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.
    Kast CE; Guggi D; Langoth N; Bernkop-Schnürch A
    Pharm Res; 2003 Jun; 20(6):931-6. PubMed ID: 12817900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH; Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
    Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
    Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
    Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of a novel cationic thiolated polymer.
    Rahmat D; Sakloetsakun D; Shahnaz G; Perera G; Kaindl R; Bernkop-Schnürch A
    Int J Pharm; 2011 Jun; 411(1-2):10-7. PubMed ID: 21382457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiomers for oral delivery of hydrophilic macromolecular drugs.
    Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
    Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
    Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A
    J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
    Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved paracellular uptake by the combination of different types of permeation enhancers.
    Guggi D; Bernkop-Schnürch A
    Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
    Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
    Anwar M; Warsi MH; Mallick N; Akhter S; Gahoi S; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Sci; 2011 Oct; 44(3):241-9. PubMed ID: 21864678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
    Bernkop-Schnürch A; Pinter Y; Guggi D; Kahlbacher H; Schöffmann G; Schuh M; Schmerold I; Del Curto MD; D'Antonio M; Esposito P; Huck C
    J Control Release; 2005 Aug; 106(1-2):26-33. PubMed ID: 15939501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.